Lipoprotein(a) and Stroke Risk in Over 16,000 Hispanic/Latino Adults: Emerging Insights From the HCHS/SOL Study
Stroke AHA/ASA Journal recently shared a post on X:
”Lipoprotein(a) and Stroke Risk: New Evidence From the Hispanic Community Health Study (HCHS/SOL). In this Blogging Stroke post, Qinglan “Priscilla” Ding discusses Stroke article by Chandra & Duran Luciano et al. AHA Journals – Melissa Lamar, Freddie Marquez.”
Read the article here.
A recent analysis from the Hispanic Community Health Study/Study of Latinos (HCHS/SOL), featured in Stroke and discussed in a Blogging Stroke commentary by Qinglan “Priscilla” Ding, sheds new light on the role of lipoprotein(a) [Lp(a)] in cerebrovascular health.
The study by Chandra, Duran Luciano, and colleagues identifies elevated Lp(a) as a significant risk marker not only for overt stroke but also for subclinical cerebrovascular injury detectable on MRI.
These associations are particularly meaningful for Hispanic/Latino populations, who have been historically underrepresented in cardiovascular research.
As Lp(a)-lowering therapies like olpasiran and pelacarsen advance in development, the findings underscore the potential of incorporating Lp(a) screening into targeted stroke prevention strategies for high-risk groups.
Discover more on stroke management in Hemostasis Today.
-
Aug 26, 2025, 10:02Women’s Equality Day: HFA Recognizes Women with Bleeding Disorders
-
Aug 26, 2025, 09:59Rare Disease Advisor – RBC Rheology Alterations in Hemophilia with Arthropathy
-
Aug 26, 2025, 09:57HFA Supports Future Planning for People with Bleeding Disorders
-
Aug 26, 2025, 09:56Phillip Taboada: TXA Shows No Added Benefit in Aquablation
-
Aug 26, 2025, 09:50A Global Collaboration: PERT Consortium Expands Reach in PE Care
-
Aug 26, 2025, 09:54TSUBASA Study: Emicizumab Improves Daily Life and Motivation in Hemophilia A Patients
-
Aug 26, 2025, 09:38Advancing CAT Care: New Insights on Extended Anticoagulation from Gerotziafas and Tafur
-
Aug 26, 2025, 09:35Alexander Mazein: Innovative Insights into Cytokine Release Syndrome via a Novel Explorable Model for Biotherapeutics and Cellular Therapies
-
Aug 25, 2025, 10:40Maria Filomena Ruberto on The Hypercoagulable State
-
Aug 25, 2025, 09:19Parham Dastjerdi – Clonal Hematopoiesis and VTE Risk
-
Aug 18, 2025, 23:56Dr. Arun V. J Invites You to His Lecture on ‘AI and Data Sciences in Transfusion Medicine’ at the AI in Healthcare Conclave. Register now!
-
Aug 18, 2025, 23:50Safe and Efficient Thrombectomy with Artix System: Clinical Insights from Neil Desai and Colleagues
-
Aug 16, 2025, 14:42Mark Crowther Honors Davide Matino for Leading Promising Hemophilia Trial at McMaster University
-
Aug 14, 2025, 10:28Impressive 95% Clot Removal in a VTE Case: Symphony16F and Symphony24F Catheters
-
Jul 28, 2025, 14:55HORIBA Decoding High Efficiency in Hematology Lab: Free Online Workshop
-
Aug 26, 2025, 09:42David McIntosh Highlights Global Blood Shortages and Fresh vs Stored RBCs
-
Aug 23, 2025, 07:48Protecting Heart and Brain Health: Stroke Prevention in Women with Bleeding Disorders: NBDF
-
Aug 21, 2025, 15:08Global Variations in Blood Collection: What Explains the Differences?
-
Aug 20, 2025, 13:33Askat's Life with Hemophilia A after Access to Prophylactic Treatment Through the WFH Humanitarian Aid Program
-
Aug 19, 2025, 17:22Louise Bannon Encourages You to Support World Thrombosis Day!